| Complement factor B mutations in atypical hemolytic uremic syndrome—disease-relevant or benign? MC Marinozzi, L Vergoz, T Rybkine, S Ngo, S Bettoni, A Pashov, M Cayla, ... Journal of the American Society of Nephrology 25 (9), 2053-2065, 2014 | 115 | 2014 |
| Global microRNA profiling in human urinary exosomes reveals novel disease biomarkers and cellular pathways for autosomal dominant polycystic kidney disease TA Magayr, X Song, AJ Streets, L Vergoz, L Chang, MK Valluru, HL Yap, ... Kidney International 98 (2), 420-435, 2020 | 46 | 2020 |
| Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions ZD Békássy, AC Kristoffersson, M Cronqvist, LT Roumenina, T Rybkine, ... Nephrology Dialysis Transplantation 28 (11), 2899-2907, 2013 | 33 | 2013 |
| Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression AJ Streets, TA Magayr, L Huang, L Vergoz, S Rossetti, RJ Simms, ... American Journal of Physiology-Renal Physiology 312 (4), F577-F588, 2017 | 29 | 2017 |
| A new ultrasonic rheometer for space exploration in lander missions M Schirru, R Dwyer-Joyce, L Vergoz Rheologica Acta 58 (1), 47-61, 2019 | 5 | 2019 |
| Identification of new miRNAs and genes networks in the pathogenesis of Autosomal Dominant Polycystic Kidney Disease (ADPKD) L Vergoz University of Sheffield, 2017 | | 2017 |
| Large spectrum of Factor B aHUS mutations functional consequences on the C3 convertase–From gain to lack of functional consequence LT Roumenina, L Vergoz, T Rybkine, R Donadelli, M Cayla, R Smith, ... Immunobiology 11 (217), 1180-1181, 2012 | | 2012 |
| Global microRNA profiling in human urinary exosomes reveals novel disease biomarkers and cellular pathways for Autosomal Dominant Polycystic Kidney Disease F Tam, TA Magayr, X Song, AJ Streets, L Vergoz, L Chang, MK Valluru, ... Elsevier, 0 | | |
